Citations

Clear

2303 citation(s) found for "Yu, Edward".

Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies
Männistö, Satu , Smith‐Warner, Stephanie A. , Anderson, Kristin E. , Brandt, Piet A. van den , Cerhan, James R. , Colditz, Graham A. , Feskanich, Diane , Freudenheim, Jo L. , Giovannucci, Edward L. , Goldbohm, R. Alexandra, Graham, Saxon, Miller, Anthony B. , Rohan, Thomas E. , Virtamo, Jarmo, Spiegelman, Donna , Albanes, Demetrius , Willett, Walter C. , Hunter, David J. , Cerhan, James R , Colditz, Graham A

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | March 22, 2006 | Volume: 13 | Issue: 1 | Pages: 40-48

10.1158/1055-9965.epi-038-3 | PMID 14744731 Get It

Abstract Intervention trials with supplemental β-carotene have observed either no effect or a harmful effect on lung cancer risk. Because food composition databases for specific carotenoids have only become available recently, epidemiological evidence relating usual dietary levels of these carotenoids with lung cancer risk is limited. We analyzed the association between lung cancer risk and intakes of specific carotenoids using the primary data from seven cohort studies in North America and Europe. Carotenoid intakes were estimated from dietary questionnaires administered at baseline in each study. We calculated study-specific multivariate relative risks (RRs) and combined these using a random-effects model. The multivariate models included smoking history and other potential risk factors. During follow-up of up to 7–16 years across studies, 3,155 incident lung cancer cases were diagnosed among 399,765 participants. β-Carotene intake was not associated with lung cancer risk (pooled multivariate RR = 0.98; 95% confidence interval, 0.87–1.11; highest versus lowest quintile). The RRs for α-carotene, lutein/zeaxanthin, and lycopene were also close to unity. β-Cryptoxanthin intake was inversely associated with lung cancer risk (RR = 0.76; 95% confidence interval, 0.67–0.86; highest versus lowest quintile). These results did not change after adjustment for intakes of vitamin C (with or without supplements), folate (with or without supplements), and other carotenoids and multivitamin use. The associations generally were similar among never, past, or current smokers and by histological type. Although smoking is the strongest risk factor for lung cancer, greater intake of foods high in β-cryptoxanthin, such as citrus fruit, may modestly lower the risk.
Polypropylene Mesh Tape for Stress Urinary Incontinence: Complications of Urethral Erosion and Outlet Obstruction
SWEAT, SUSAN D., Itano, Nancy B., Bushman, Wade , Gruenenfelder, Jennifer, McGuire, Edward J., Lightner, Deborah J., Clemens, J. Quentin

Mayo Clinic

Journal of Urology | January 17, 2006 | Volume: 168 | Issue: 1 | Pages: 144-146

10.1016/s0022-5347(05)64848-3 Get It

Sustained Reverse Left Ventricular Structural Remodeling With Cardiac Resynchronization at One Year Is a Function of Etiology
Sutton, Martin G. St. John, Plappert, Ted, Hilpisch, Kathryn, Abraham, William T. , Hayes, David L. , Chinchoy, Edward

Mayo Clinic

Circulation | January 10, 2006 | Volume: 113 | Issue: 2 | Pages: 266-272

10.1161/circulationaha.104.520817 | PMID 16401777 Get It

Background— Cardiac resynchronization therapy (CRT) is an effective therapy for patients with moderate to severe heart failure and prolonged QRS duration. The purpose of this study was to determine whether reverse left ventricular (LV) remodeling and symptomatic benefit from CRT were sustained at 12 months, and if so, in what proportion of patients this occurred. Methods and Results— Serial Doppler echocardiograms were obtained at baseline and 6 and 12 months after CRT in 228 patients enrolled in the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) trial. Measurements were made of LV end-diastolic (EDV) and end-systolic (ESV) volumes, ejection fraction, LV mass, severity of mitral regurgitation (MR), peak transmitral velocities during early (E wave) and late (A wave) diastolic filling, and myocardial performance index. At both 6 and 12 months, respectively, CRT was associated with reduced LV EDV ( P <0.0001 and P =0.007) and LV ESV ( P <0.0001 and P <0.0001), improved ejection fraction ( P <0.0001 and P <0.0001), regression of LV mass ( P =0.012 and P <0.0001), and reduced MR ( P <0.0001 and P <0.0001). LV filling time, transmitral E/A ratio, and myocardial performance index all improved at 12 months compared with baseline ( P <0.001, P =0.031, and P <0.0001). Reverse LV remodeling with CRT occurred in more patients at 6 than at 12 months (74% versus 60%, respectively; P <0.05) and was greater in patients with a nonischemic than an ischemic etiology. Conclusions— Reverse LV remodeling and symptom benefit with CRT are sustained at 12 months in patients with New York Heart Association class III/IV heart failure but occur to a lesser degree in patients with an ischemic versus a nonischemic etiology, most likely owing to the inexorable progression of ischemic disease.
Mutation Scanning of the RET Protooncogene Using High-Resolution Melting Analysis
Margraf, Rebecca L. , Mao, Rong , Highsmith, W. Edward, Holtegaard, Leonard M., Wittwer, Carl T.

Mayo Clinic

Clinical Chemistry | January 3, 2006 | Volume: 52 | Issue: 1 | Pages: 138-141

10.1373/clinchem.2005.052951 | PMID 16391329 Get It

Abstract Background: Single-base pair missense mutations in exons 10, 11, 13, 14, 15, and 16 of the RET protooncogene are associated with the autosomal dominant multiple endocrine neoplasia type 2 (MEN2) syndromes: MEN2A, MEN2B, and familial medullary thyroid carcinoma. The current widely used approach for RET mutation detection is sequencing of the exons. Methods: Because RET mutations are rare and the majority are heterozygous mutations, we investigated RET mutation detection by high-resolution amplicon melting analysis. This mutation scanning technique uses a saturating double-stranded nucleic acid binding dye, LCGreen®, and the high-resolution melter, HR-1™, to detect heterozygous and homozygous sequence variations. Mutant genotypes are distinguished from the wild-type genotype by an altered amplicon melting curve shape or position. Results: Samples of 26 unique RET mutations, 4 nonpathogenic polymorphisms, or the wild-type genotype were available for this study. The developed RET mutation-scanning assay differentiated RET sequence variations from the wild-type genotype by altered derivative melting curve shape or position. A blinded study of 80 samples (derived from the 35 mutant, polymorphism, or wild-type samples) demonstrated that 100% of RET sequence variations were differentiated from wild-type samples. For exons 11 and 13, the nonpathogenic polymorphisms could be distinguished from the pathogenic RET mutations. Some RET mutations could be directly genotyped by the mutation scanning assay because of unique derivative melting curve shapes. Conclusion: RET high-resolution amplicon melting analysis is a sensitive, closed-tube assay that can detect RET protooncogene sequence variations.
Transforming Growth Factor-β Activation of Phosphatidylinositol 3-Kinase Is Independent of Smad2 and Smad3 and Regulates Fibroblast Responses via p21-Activated Kinase-2
Wilkes, Mark C. , Mitchell, Hugh , Penheiter, Sumedha G., Doré, Jules J.E., Suzuki, Kaori , Edens, Maryanne, Pagano, Richard E., Leof, Edward B. , Sharma, Deepak

Mayo Clinic

Cancer Research | November 15, 2005 | Volume: 65 | Issue: 22 | Pages: 10431-10440

10.1158/0008-5472.can-05-1522 | PMID 16288034 Get It

Abstract Transforming growth factor-β (TGF-β) stimulates cellular proliferation and transformation to a myofibroblast phenotype in vivo and in a subset of fibroblast cell lines. As the Smad pathway is activated by TGF-β in essentially all cell types, it is unlikely to be the sole mediator of cell type–specific outcomes to TGF-β stimulation. In the current study, we determined that TGF-β receptor signaling activates phosphatidylinositol 3-kinase (PI3K) in several fibroblast but not epithelial cultures independently of Smad2 and Smad3. PI3K activation occurs in the presence of dominant-negative dynamin and is required for p21-activated kinase-2 kinase activity and the increased proliferation and morphologic change induced by TGF-β in vitro.
An Experimental Study of Temperatures Produced by Ultrasonic Radiations in Bone Marrow, Bone, and Adjacent Tissues
Baldes, Edward J., Nelson, Paul A., Herrick, J. F.

Mayo Clinic

The Journal of the Acoustical Society of America | September 30, 2005 | Volume: 22 | Issue: 5_Supplement | Pages: 682-682

10.1121/1.1917223 Get It

As early as 1932 Freundlich, Sollner, and Rogowski proposed the use of ultrasonics in medicine for diathermy. They were able to demonstrate that bone marrow could be heated. The results of their study indicated clearly that further experiments needed to be done to extend these preliminary observations. We have completed a study of the temperatures produced by ultrasonics in bone marrow, bone, and adjacent tissues in the extremities of the dog. The frequency used in these studies was 800 kilocycles per second. The maximum output of the ultrasonic generator was approximately 15 watts. High temperatures can be produced in bone marrow and bone with relatively low outputs of ultrasonic energy. The adjacent tissues are heated only moderately. Ultrasonics must be used with caution in the proximity of bones because the temperatures produced in bone and bone marrow may rise to dangerous levels within a very few minutes.
Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel
Svingen, Phyllis A., Loegering, David A., Rodriquez, Joe, Meng, Xue , Mesner, Peter W., Holbeck, Susan L., Monks, Anne, Krajewski, Stan, Scudiero, Dominic A., Sausville, Edward A., Reed, John C. , Lazebnik, Yuri, Kaufmann, Scott H.

Mayo Clinic

Clinical Cancer Research | September 21, 2005 | Volume: 10 | Issue: 20 | Pages: 6807-6820

10.1158/1078-0432.ccr-0778-02 | PMID 15501957 Get It

Abstract Purpose: According to some studies, susceptibility of cells to anticancer drug-induced apoptosis is markedly inhibited by targeted deletion of genes encoding apoptotic protease activating factor 1 (Apaf-1) or certain caspases. Information about levels of these polypeptides in common cancer cell types and any possible correlation with drug sensitivity in the absence of gene deletion is currently fragmentary. Experimental Design: Immunoblotting was used to estimate levels of Apaf-1 as well as procaspase-2, -3, -6, -7, -8, and -9 in the 60-cell-line panel used for drug screening by the National Cancer Institute. Sensitivity of the same lines to &gt;80,000 compounds was determined with 48-hour sulforhodamine B binding assays. Additional 6-day assays were performed for selected agents. Results: Levels of Apaf-1 and procaspases varied widely. Apaf-1 and procaspase-9, which are implicated in caspase activation after treatment of cells with various anticancer drugs, were detectable in all of the cell lines, with levels of Apaf-1 ranging from ∼1 × 105 to 2 × 106 molecules per cell and procaspase-9 from ∼5 × 103 to ∼1.6 × 105 molecules per cell. Procaspase-8 levels ranged from 1.7 × 105 to 8 × 106 molecules per cell. Procaspase-3, a major effector caspase, varied from undetectable to ∼1.6 × 106 molecules per cell. Correlations between levels of these polypeptides and sensitivity to any of a variety of experimental or conventional antineoplastic agents in either 2-day or 6-day cytotoxicity assays were weak at best. Conclusions: With the exception of caspase-3, all of the components of the core cell-death machinery are expressed in all of the cell lines examined. Despite variations in expression, levels of any one component are not a major determinant of drug sensitivity in these cells in vitro.
Nitric oxide-based pathomechanism of delayed cerebral vasospasm after SAH
Jung, Carla S. , Iuliano, Brian A., Oldfield, Edward H., Pluta, Ryszard

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | September 2, 2005 | Volume: 25 | Issue: 1_suppl | Pages: S124-S124

10.1038/sj.jcbfm.9591524.0124 Get It

[O2‐01‐03]: Volume MRI study: The effects of Coenzyme Q10 in APP/PS1 mouse models of Alzheimer's disease and cerebral ischemia
Li, Geng , Yang, Edward , Zou, Liang , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | August 25, 2005 | Volume: 1 | Issue: 1S_Part_3 | Pages: No page available

10.1016/j.jalz.2005.06.328 Get It

[P‐203]: Coenzyme Q10 inhibited the opening of the mitochondrial permeability transition pore to protect SHSY5Y neuronal cells
Li, Geng , Clifford, Jack, Yang, Edward E.S., Zou, Liang

Mayo Clinic

Alzheimer's & Dementia | August 25, 2005 | Volume: 1 | Issue: 1S_Part_2 | Pages: No page available

10.1016/j.jalz.2005.06.261 Get It